Pharma Likelihood Of Approval
We are the trusted, gold standard intelligence provider to the world’s largest industries
GlobalData powers faster, more informed decisions with:
- Granular industry intelligence: We develop deep, vertical-specific intelligence tailored to your industry, providing 360° insight.​
- Exhaustive coverage: We synthesize our vast data universe into formats that support your decision-making needs, covering the sectors, themes, companies and geographies that matter to you. ​
- Proprietary datasets: We provide you with access to untapped pools of intelligence generated from our proprietary datasets and primary research capabilities. ​
- Robust methodologies: The quality and timeliness of our data is a key differentiator. We leverage robust research methodologies to turn millions of data points into trusted intelligence.
Thousands of companies, government organizations, and decision makers rely on GlobalData
We have a track record of serving truly diverse clients, including:
- Corporates: From helping the C-suite refine strategy to powering innovation in marketing and R&D, our corporate use cases are endless. ​
- Investment firms: We help financial analysts develop robust long-term strategies and get alpha signals before the rest. ​
- Professional services: We give consultants, legal, and accounting firms the critical insights to make faster, more informed decisions. ​
- Other sectors: From media to academia, we work with sectors as diverse as our data. ​
The trusted, actionable and future-proof insight you need to stay ahead
We have decades of experience in being the gold standard intelligence provider based on: ​
- Unique data: Proprietary datasets built from terabytes of data. Our unmatched intelligence gives you true strategic advantage.
- Expert analysis: Leverage collective expertise. Count on our extensive team of researchers, analysts, subject matter experts, and journalists, plus thousands of external thought-leaders.​
- Real intelligence over AI: Experience a level of analysis that leaves AI in the dust. Unlock the proprietary datasets unseen by AI and gain a decisive edge. ​
- Time-saving research solutions: Save hundreds of hours on research. Our comprehensive reports let you focus on delivering actionable insights - not searching for them. ​
- Unparalleled global coverage: Tap into insights from anywhere. Our extensive global coverage offers an unrivalled view of the market landscape.​
- One platform: Access all our unique data, expert analysis, and innovative solutions on one platform. ​
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - RZL-12 in Adiposis Dolorosa (Dercum's Disease or Anders Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RZL-12 in Adiposis Dolorosa (Dercum's Disease or Anders Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RZL-12 in Adiposis Dolorosa (Dercum's Disease or Anders...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Bupivacaine Hydrochloride in Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bupivacaine Hydrochloride in Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Bupivacaine Hydrochloride in Oral MucositisDrug Details:Bupivacaine hydrochloride is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Volixibat Potassium in Primary Sclerosing Cholangitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Volixibat Potassium in Primary Sclerosing Cholangitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Volixibat Potassium in Primary Sclerosing CholangitisDrug Details:Volixibat potassium (SHP-626, LUM-002) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Maralixibat Chloride in Biliary Atresia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Maralixibat Chloride in Biliary Atresia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Maralixibat Chloride in Biliary AtresiaDrug Details:Maralixibat chloride (Livmarli) is an anti-pruritus agent....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Cannabidiol in Fragile X Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cannabidiol in Fragile X Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Cannabidiol in Fragile X SyndromeDrug Details:Cannabidiol (ZYN-002) is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - BMS-986263 in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-986263 in Liver Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BMS-986263 in Liver CirrhosisDrug Details:BMS-986263 (ND-L02-s0201) is under development for the treatment of non-alcoholic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Filgrastim in Chemotherapy Induced Neutropenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Filgrastim in Chemotherapy Induced Neutropenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Filgrastim in Chemotherapy Induced NeutropeniaDrug Details:Filgrastim (Lupifil) is a recombinant, granulocyte colony...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Mavacamten in Diastolic Heart Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mavacamten in Diastolic Heart Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Mavacamten in Diastolic Heart FailureDrug Details: Mavacamten (Camzyos) is an allosteri a...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Cemdisiran in Hematuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cemdisiran in Hematuria report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cemdisiran in Hematuria Drug Details: Cemdisiran is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Eladocagene Exuparvovec in Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eladocagene Exuparvovec in Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Eladocagene Exuparvovec in Aromatic l-Amino Acid Decarboxylase (AADC)...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.